Navigation Links
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Date:1/12/2009

ABBOTT PARK, Ill. and SANTA ANA, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Advanced Medical Optics (AMO) (NYSE: EYE) announced today a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of closing. Based in Santa Ana, Calif., AMO is a global leader in ophthalmic care, comprised of three segments: cataract surgery, laser vision correction (LASIK), and eye care products. Globally, AMO holds the number one position in LASIK surgical devices, the number two position in the cataract surgical device market and the number three position in contact lens care products.

"Through superior vision care technologies and service, AMO has established itself as a leader in this multi-billion dollar medical device segment. With AMO, Abbott is enhancing and strengthening its diverse mix of medical device businesses and gaining a leadership position in another large and growing segment," said Miles D. White, chairman and chief executive officer, Abbott. "Additionally, Abbott's significant global presence will help drive growth opportunities for this business, especially in international markets, where favorable demographics are driving demand for advanced eye care procedures and products."

"This transaction underscores the fundamental value of the AMO franchise, the talent and expertise of our global team, and the strength of our product offering, pipeline and strategy to provide refractive vision care for people of all ag
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Abbott Announces Earnings Guidance for 2009
2. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
3. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
4. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
5. Abbott Hosts Conference Call for Third-Quarter Earnings
6. Abbott to Present at UBS Best of Americas Investment Conference
7. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
8. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
9. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
10. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... SEATTLE, Nov. 20 Cell T...ounced today that the Ninth Circuit Court of Appea...that CTI should be allowed to pursue all of its cl... to the District Court for trial. CTI filed a com...party reimbursement consultant for CTI,s product T...
(Date:11/19/2009)...e would like to be able to charge their cell phone...oo often. A recent discovery made by UC San Diego ...rcapacitors that could do just this. , In recen..., Prabhakar Bandaru, a professor in the UCSD Depar...ng with graduate student Mark Hoefer, have found t...
(Date:11/19/2009)...UVELT, N.Y., Nov. 19 Dr. Mate Hidv...ct, responds to a press release issued on November...company for making false and self-serving statemen... ,, Dr. Hidvegi stated from his office in Buda...esearch on Avemar does not apply to AveULTRA, ww...
(Date:11/19/2009)...HESDA, Md., Nov. 19 Sphe... biotechnology for diabetes therapy, and a provide...to food, supplement, biotechnology and pharmaceuti...day,s Annual Meeting of Shareholders. ,, At the...sdaq: SPEX ) elected the following members to the...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
... - In an effort to spur growth in the community a...sin-Whitewate r graduates, the city of Whitewater... UW-Whitewater are developing a business incubator...rnal. , ,The city, which last year received a $10,...f successful and unsuccessful incubators throughou...
... from Los Angeles, where I served as a judge for a...,Instead, 14 other jurors and I were locked in a c...ernational Airport . Over three days, we carefully...s Medical Design Excellence Awards (MDEA). , ,Wh..., the MDEA winners may very well save your life so...
...- RedPrairie Corp. has signed a definitive agree...management software based in Quebec City, Canada. ...cquisition is expected to close by the end of Febr...software, said the combined companies will operate...l Transportation Group will integrate and oversee ...
Other Biology Technology:And the winners in medical design are 2And the winners in medical design are 3And the winners in medical design are 4And the winners in medical design are 5And the winners in medical design are 6
(Date:11/22/2009)...esearch Centre, a partnership of the University of...r Coastal Health Research Institute, have uncovere...in cells die following a stroke, as well as a poss...he study were recently published online in Nature...ls continue to die even after blood flow has been ...
(Date:11/20/2009)... work on many scientific and technological frontie...rovided support that totals nearly $4.3 million fo...rs under the American Recovery and Reinvestment Ac...d grants for investigation of solar phenomena. Phi...will enhance the capabilities of NJIT,s Big Bear S...
(Date:11/20/2009)...all read studies about the health benefits of havi...olecular level, where amino acids known as cystein...than when paired up with other cysteines. , Now,...with colleagues in Belgium, have discovered a new ... The research appears in the Nov. 20 issue of the ...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Saving the single cysteine: New antioxidant system found 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 1Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 5Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 1Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 2Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 3
...champions of organ regrowth because they direct th...r organs, according to research published in the o...gy. The discovery that Holothuria glaberrima uses ...nd organ regeneration gives us the opportunity to ... eventually, how to regenerate body parts. , The ...
...State University and the University of Bucharest, ...ies Cycloprosopon dobrogea in eastern Romania. Pre...rosopidae family existed more than 150 million yea...imitive and extant crabs helps determine various a...such as when arthropods diversified, says Dr. Carr...
... why you inherited your mothers smile but not your...f Leeds and Dundee are one step closer to unravell... DNA to create genetically unique offspring. , In...Phillips, Dr Stephen Carr and Dr Jonathan Hadden, ...ve mapped the 3 dimensional structure of an enzyme...
Other Biology News:Sea cucumbers fast track organ regrowth by healing their wounds 2
PyAOP from Applied Biosystems
Nunc MicroWell Mini Trays from Invitrogen
E. coli Expression System with Gateway Technology from Invitrogen
GIBCO Leibovitz's L-15 Medium powder from Invitrogen
Biology Products: